ARTICLE | Company News
SkyePharma gets FDA approvable letter
September 28, 2000 7:00 AM UTC
SkyePharma (LSE:SKP; SKYE) received an FDA approvable letter for Solarase, a topical gel formulation of the non-steroidal anti-inflammatory drug diclofenac to treat actinic keratosis. ...